[go: up one dir, main page]

CL2014000020A1 - Metodo para tratar tos post-viral, tos viral o tos aguda viral; compuestos heterociclicos de formula (iv); composicion farmaceutica que los comprende. - Google Patents

Metodo para tratar tos post-viral, tos viral o tos aguda viral; compuestos heterociclicos de formula (iv); composicion farmaceutica que los comprende.

Info

Publication number
CL2014000020A1
CL2014000020A1 CL2014000020A CL2014000020A CL2014000020A1 CL 2014000020 A1 CL2014000020 A1 CL 2014000020A1 CL 2014000020 A CL2014000020 A CL 2014000020A CL 2014000020 A CL2014000020 A CL 2014000020A CL 2014000020 A1 CL2014000020 A1 CL 2014000020A1
Authority
CL
Chile
Prior art keywords
viral cough
cough
understands
formula
pharmaceutical composition
Prior art date
Application number
CL2014000020A
Other languages
English (en)
Inventor
Roderick S Davis
Guoliang Lin
Jeffrey Charles Boehm
Jeffrey Kerns
Robert D Murdoch
Hong Nie
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47437403&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014000020(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CL2014000020A1 publication Critical patent/CL2014000020A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL2014000020A 2011-07-06 2014-01-06 Metodo para tratar tos post-viral, tos viral o tos aguda viral; compuestos heterociclicos de formula (iv); composicion farmaceutica que los comprende. CL2014000020A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161505075P 2011-07-06 2011-07-06

Publications (1)

Publication Number Publication Date
CL2014000020A1 true CL2014000020A1 (es) 2014-08-01

Family

ID=47437403

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000020A CL2014000020A1 (es) 2011-07-06 2014-01-06 Metodo para tratar tos post-viral, tos viral o tos aguda viral; compuestos heterociclicos de formula (iv); composicion farmaceutica que los comprende.

Country Status (21)

Country Link
US (1) US20140121213A1 (es)
EP (1) EP2729149A4 (es)
JP (1) JP2014518281A (es)
KR (1) KR20140059774A (es)
CN (1) CN103764148A (es)
AR (1) AR087053A1 (es)
AU (1) AU2012279091A1 (es)
BR (1) BR112014000259A2 (es)
CA (1) CA2840394A1 (es)
CL (1) CL2014000020A1 (es)
CO (1) CO6821963A2 (es)
CR (1) CR20140002A (es)
DO (1) DOP2014000001A (es)
EA (1) EA201490210A1 (es)
MA (1) MA35336B1 (es)
MX (1) MX2014000112A (es)
PE (1) PE20141385A1 (es)
PH (1) PH12014500006A1 (es)
TW (1) TW201302707A (es)
WO (1) WO2013006596A1 (es)
ZA (1) ZA201309533B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9346798B2 (en) 2012-02-13 2016-05-24 Amgen Inc. Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
US9051311B2 (en) 2012-03-09 2015-06-09 Amgen Inc. Sulfamide sodium channel inhibitors
BR112015022385A2 (pt) * 2013-03-14 2017-07-18 Daiichi Sankyo Co Ltd droga para uma doença respiratória
US10668067B2 (en) 2016-07-20 2020-06-02 Amgen Inc. Pyridine sulfonamides
WO2020120673A1 (en) 2018-12-13 2020-06-18 Intervet International B.V. Process for preparing 1-[(3r,4s)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]p yrazole-4-carboxamide
CN109796402A (zh) * 2018-12-28 2019-05-24 京博农化科技有限公司 一种烟嘧磺隆中间体2-氯-n,n-二甲基烟酰胺的制备方法
EP4405347A1 (en) 2021-09-24 2024-07-31 Xenon Pharmaceuticals Inc. Pyridine derivatives and their use as sodium channel activators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008147864A2 (en) * 2007-05-22 2008-12-04 Xenon Pharmaceuticals Inc. Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
TW201139406A (en) * 2010-01-14 2011-11-16 Glaxo Group Ltd Voltage-gated sodium channel blockers

Also Published As

Publication number Publication date
AU2012279091A1 (en) 2014-01-16
ZA201309533B (en) 2014-08-27
EP2729149A1 (en) 2014-05-14
EP2729149A4 (en) 2015-01-07
KR20140059774A (ko) 2014-05-16
CO6821963A2 (es) 2013-12-31
CR20140002A (es) 2014-03-05
MA35336B1 (fr) 2014-08-01
WO2013006596A1 (en) 2013-01-10
EA201490210A1 (ru) 2014-05-30
MX2014000112A (es) 2014-01-31
AR087053A1 (es) 2014-02-12
CN103764148A (zh) 2014-04-30
CA2840394A1 (en) 2013-01-10
US20140121213A1 (en) 2014-05-01
JP2014518281A (ja) 2014-07-28
TW201302707A (zh) 2013-01-16
BR112014000259A2 (pt) 2017-02-14
DOP2014000001A (es) 2014-04-30
PE20141385A1 (es) 2014-10-29
PH12014500006A1 (en) 2014-02-10

Similar Documents

Publication Publication Date Title
HRP20190074T1 (hr) Aril-ili heteroaril-supstituirani spojevi benzena
DK3366293T3 (da) Dihydronaphthyridiner og relaterede forbindelser, der er nyttige som kinashæmmere til behandling af proliferative sygdomme
DK4190786T3 (da) Forbindelser, der er nyttige som hæmmere af atr-kinase
CL2014003035A1 (es) Compuestos derivados de diazabiciclooctano, inhibidores de beta-lactamasa; composicion farmaceutica que los comprende; proceso para prepararlos; y metodo para tratar una infeccion bacteriana.
BR112015001596A2 (pt) composição para o tratamento de hiperlipidemia que compreende oxintomodulina.
DK2791134T3 (da) Kemisk forbindelse, der er anvendelig som mellemprodukt til fremstilling af en catechol-o-methyltransferasehæmmer
CL2014000020A1 (es) Metodo para tratar tos post-viral, tos viral o tos aguda viral; compuestos heterociclicos de formula (iv); composicion farmaceutica que los comprende.
BR112014010197A2 (pt) composto, composição farmacêutica, método de tratamento de um distúrbio
CL2014000814A1 (es) Compuestos derivados de piridazinona; composicion herbicida que los comprende; y metodo para controlar malezas.
CO7160104A2 (es) Inhibidores de virus de hepatitis c
DK3330257T3 (da) Pyrimidinderivater til behandling af virusinfektioner
BR112014003587A8 (pt) Derivados de 5-flúor-4-imino-3-(substituído)-3,4-dihidropirimidin-2(1h)ona, composição e método para controle ou prevenção de um patógeno fúngico
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
CL2014002640A1 (es) Compuestos pirrolidin, piperidin o azepan sustituidos, inhibidores de met-ap2; procedimiento para prepararlos; y medicamento que los contiene.
BR112016014020A8 (pt) moduladores de tetra-hidropiridopirazinas de gpr6.
BR112014000033A2 (pt) compostos para o tratamento de dependência química
DK2678329T3 (da) Triazolopyridinforbindelser som pim-kinase-hæmmere
CO6940429A2 (es) Compuestos heterocíclicos, medicamentos que los contienen, uso de aquellos y procesos para su preparación
CR20140263A (es) Composicion herbicida que contiene acido de 4-amino-3-cloro-6-(-4-cloro-2-fluor-3-metoxifenil) piridina-2-carboxilico, o los derivados del mismo y fluroxipir, o los derivados del mismo
BR112015007159A2 (pt) compostos heterocíclicos que contêm azoto para o controle de doenças de plantas
EP2759543A4 (en) CHROMENIC COMPOUND AND HARDENABLE COMPOSITION
BR112014006420A2 (pt) compostos, composição farmacêutica, uso de um composto e mètodo para o tratamento ou profilaxia
CO6960548A2 (es) Polimorfos de arry-380, un inhibidor selectivo de herb2 y composiciones farmacéuticas que los contienen
BR112015003101A2 (pt) processo para a preparação de um composto.
BR112014028622A2 (pt) composições de ativador de glucoquinase para o tratamento de diabetes